scholarly journals Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers

2015 ◽  
Vol 468 (1) ◽  
pp. 31-41 ◽  
Author(s):  
Lien Tembuyser ◽  
Elisabeth M. C. Dequeker
Author(s):  
Michael D. Palmer ◽  
Shila Seaton

This chapter examines the roles of biosafety and quality assurance (with emphasis on the importance of external quality assessment) and demonstrates their importance in a clinical mycology laboratory setting. Their practice and combination are required to ensure the provision of precise and accurate analyses in a safety-focused environment to support optimal patient care.


2012 ◽  
Vol 462 (1) ◽  
pp. 27-37 ◽  
Author(s):  
J. Han van Krieken ◽  
Nicola Normanno ◽  
Fiona Blackhall ◽  
Elke Boone ◽  
Gerardo Botti ◽  
...  

2006 ◽  
Vol 96 (11) ◽  
pp. 597-601 ◽  
Author(s):  
Anne Goodeve ◽  
Marian Hill ◽  
Ian Jennings ◽  
Steve Kitchen ◽  
Isobel Walker ◽  
...  

SummaryMolecular genetic analysis of families with haemophilia and other inherited bleeding disorders is nowa common laboratory investigation. In contrast to phenotypic testing in which strict quality control is adhered to, in haemophilia molecular genetic testing there has been a lack of any external quality assurance schemes. In 1998 the UK National External Quality Assessment Scheme (UK NEQAS) established a pilot quality assurance scheme for molecular genetic testing in haemophilia. Results from three initial surveys highlighted problems with the quality of samples when used to screen for the intron 22 inversion within the F8 gene. The scheme was re-launched in 2003, and since that time there have been five exercises involving whole blood or immortalised cell line DNA. The results together with an overall summary of the exercise are subsequently returned to participants. Exercises to date have focused exclusively on haemophilia A and QA, material has included screening for the intron 1 and intron 22 inversions as well as sequence analysis. A paper exercise circulated in 2003 highlighted problems with the format of reports and, following feedback to participants, onlya single error has been made in the subsequent four exercises. Participating laboratories now receive QA material every six months. Immortalised cell line material was introduced in 2005 and was shown to perform well. This will allow expansion of the scheme and a reduction in the dependence on blood donation.


2017 ◽  
Vol 5 (S2) ◽  
pp. AB022-AB022
Author(s):  
Rosalind Hastings ◽  
Conny van Ravenswaaij-Arts ◽  
Christi van Asperen ◽  
Borut Peterlin ◽  
Livia Garavelli

2013 ◽  
Vol 24 (8) ◽  
pp. 1958-1963 ◽  
Author(s):  
J.H. van Krieken ◽  
A.G. Siebers ◽  
N. Normanno ◽  
F. Blackhall ◽  
E. Boone ◽  
...  

Author(s):  
S. M. Lewis

SynopsisQuality assurance in laboratory haematology includes (a) constant checking of test reliability by internal quality control, (b) external quality assessment by an independent agency to check performance of a number of laboratories at intervals in order to obtain a retrospective indication of their ability and (c) proficiency control by supervision of the pre-test and post-test phases of laboratory work, from specimen collection to delivery of the report to the clinician.The procedures which comprise quality control are described; these include use of control preparations with control charts, CUSUM analysis, constancy of daily means of the blood count indices of ‘absolute values’, duplicate testing, clinical correlation and the important role of the blood film to check the instrument-derived blood count measurements.A description of the functions of an external quality assessment scheme is based on the UK National Scheme (UK NEQAS). The blood count and other tests of general haematology have been used as models to describe the procedures for qualitative and quantitative tests, low results are analysed and performance is assessed. The tribulations and triumphs of NEQAS are described and it is concluded that NEQAS has a vital role in ensuring good laboratory practice in general, and the reliability of the individual laboratories who participate in the scheme. NEQAS, in turn, must ensure its own ability to provide stable materials which are suitable for each test in the programme, and to analyse data correctly. There is also need to take account of the continued expansion of laboratory services as new techniques are introduced and to develop appropriate EQA procedures and materials in order to incorporate these in a comprehensive scheme.


Sign in / Sign up

Export Citation Format

Share Document